バルトネラ症の世界市場レポート 2025年

バルトネラ症の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.7％で20億3,000万米ドルに成長します。予測期間中の成長は、人獣共通感染症の発生率の増加、病気に対する意識の高まり、ペット飼育人口の増加、個別化医療への注目の高まり、猫ひっかき病に対する意識の高まりなどに起因すると考えられます。この期間に予想される主な動向には、医療技術とバイオテクノロジーの進歩、複合検査法の開発、診断技術の向上、継続的な研究開発努力が含まれます。

人獣共通感染症の流行の増加が、今後数年間のバルトネラ症市場の成長を牽引すると予想されます。人獣共通感染症は、動物からヒトへ、直接または媒介動物を介して感染する感染症です。人獣共通感染症の急増は、人間と動物の相互作用の激化、環境の変化、森林伐採、世界の旅行、病原体の種を超えた拡散などの要因に起因しています。バルトネラ症は、ノミ、ダニ、シラミなどの動物を媒介として感染し、ヒトに感染してさまざまな臨床症状を引き起こす細菌性病原体の重要な例です。このことは、公衆衛生における媒介感染症の伝播を理解することの重要性を強調しています。例えば、2023年1月に連邦当局であるカナダ政府が発表した報告書によると、2022年10月には135検体であった狂犬病検体が、2022年11月には159検体提出されています。その結果、人獣共通感染症の発生率の増加がバルトネラ症市場の拡大に拍車をかけています。

バルトネラ症市場の主要企業は、この病気の早期発見と治療法改善のための資金調達活動を優先しています。このような取り組みには、バルトネラ症の調査、診断、治療、予防を支援するための資金を調達する組織が関与しており、それによってイノベーションが促進され、ヘルスケアソリューションへのアクセスが改善されます。例えば、米国を拠点とする非営利団体世界・ライム・アライアンス（GLA）は、2022年4月、神経炎症や精神疾患などの深刻な健康状態に関連する隠れた病原体であるバルトネラに関する先駆的な調査のため、30万米ドルを集めるクラウドファンディング・キャンペーンを開始しました。これは、バルトネラ感染症やライム病などの関連疾患に対するより効果的な治療法を開発するために不可欠なものです。このキャンペーンは、これらの衰弱性疾患に罹患した人々を支援するための、より大きな認識と資金の必要性を強調しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バルトネラ症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバルトネラ症市場：成長率分析
• 世界のバルトネラ症市場の実績：規模と成長, 2019-2024
• 世界のバルトネラ症市場の予測：規模と成長, 2024-2029, 2034F
• 世界バルトネラ症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバルトネラ症市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 猫ひっかき病（CSD）
• 塹壕熱
• バルトネラ心内膜炎
• その他の病気の種類
• 世界のバルトネラ症市場診断方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）検査
• 血清学的検査
• 培養方法
• 組織学的検査
• 世界のバルトネラ症市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 抗菌剤
• 支持療法
• 世界のバルトネラ症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断検査室
• その他のエンドユーザー
• 世界のバルトネラ症市場猫ひっかき病（CSD）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫適格宿主
• 免疫不全宿主
• 神経学的合併症
• 世界のバルトネラ症市場塹壕熱のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性塹壕熱
• 慢性塹壕熱
• 無症状感染
• 世界のバルトネラ症市場、バルトネラ心内膜炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 固有弁心内膜炎
• 人工弁心内膜炎
• 血流感染症
• 世界のバルトネラ症市場、その他の疾患タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌性血管腫症
• パリノー眼腺症候群
• バルトネラ関連血管炎

第7章 地域別・国別分析

• 世界のバルトネラ症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバルトネラ症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バルトネラ症市場：競合情勢
• バルトネラ症市場：企業プロファイル
  • Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Northwell Health Labs Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• Alberta Precision Laboratories
• Jiangsu BioPerfectus Technologies Co. Ltd.
• ARUP Laboratories
• Surmodics Inc.
• Medical Diagnostic Laboratories LLC
• Creative Biolabs
• IGeneX Inc.
• Karius Inc.
• Synnovis Group LLP
• Galaxy Diagnostics Inc.
• Gold Standard Diagnostics
• Eurofins Biomnis
• AMMAGENOMICS Private Limited
• Ringbio

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バルトネラ症市場2029：新たな機会を提供する国
• バルトネラ症市場2029：新たな機会を提供するセグメント
• バルトネラ症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bartonellosis is a bacterial infection caused by the Bartonella genus, affecting the skin, lymph nodes, and internal organs. Prompt diagnosis and antibiotic treatment are crucial to prevent severe systemic complications and ensure effective disease management.

The primary forms of bartonellosis include cat scratch disease (CSD), trench fever, Bartonella endocarditis, and others. Cat scratch disease, caused by Bartonella henselae and transmitted through cat scratches or bites, results in symptoms such as swollen lymph nodes, fever, and fatigue. Diagnosis involves various methods, including polymerase chain reaction (PCR) testing, serological testing, culture techniques, and histological examination. Treatment options consist of antibiotics, antibacterial agents, and supportive care. The disease is managed by various end-users, including hospitals and clinics, diagnostic laboratories, and others.

The bartonellosis market research report is one of a series of new reports from The Business Research Company that provides bartonellosis market statistics, including the bartonellosis industry global market size, regional shares, competitors with the bartonellosis market share, detailed bartonellosis market segments, market trends, and opportunities, and any further data you may need to thrive in the bartonellosis industry. This bartonellosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bartonellosis market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth during the historic period can be attributed to the rising prevalence of Bartonella disease, increased healthcare expenditure, greater funding for research and development, the growing incidence of transmissible illnesses, and the increasing occurrence of infectious diseases.

The bartonellosis market size is expected to see rapid growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth during the forecast period can be attributed to the increasing incidence of zoonotic diseases, rising disease awareness, a growing pet-owning population, a stronger focus on personalized medicine, and greater awareness of cat scratch disease. Key trends expected in this period include advancements in medical technology and biotechnology, the development of combined testing methods, improvements in diagnostic techniques, and continuous research and development efforts.

The increasing prevalence of zoonotic diseases is anticipated to drive the growth of the bartonellosis market in the coming years. Zoonotic diseases are infections transmitted from animals to humans, either directly or via vectors. The surge in zoonotic disease cases can be attributed to factors such as heightened human-animal interactions, environmental changes, deforestation, global travel, and the cross-species spread of pathogens. Bartonellosis serves as a significant example of a bacterial pathogen transmitted through animal vectors such as fleas, ticks, and lice, which can infect humans and cause various clinical manifestations. This underscores the importance of understanding vector-borne disease transmission in public health. For instance, in January 2023, a report published by the Government of Canada, a federal authority, indicated that 159 rabies samples were submitted in November 2022, compared to 135 samples in October 2022. Consequently, the growing incidence of zoonotic diseases is fueling the expansion of the bartonellosis market.

Leading companies in the bartonellosis market are prioritizing fundraising initiatives to enhance early detection and improve treatment options for the disease. These efforts involve organizations raising funds to support research, diagnosis, treatment, and prevention of bartonellosis, thereby fostering innovation and improving access to healthcare solutions. For example, in April 2022, the Global Lyme Alliance (GLA), a US-based nonprofit organization, launched a crowdfunding campaign to raise $300,000 for pioneering research on Bartonella, a hidden pathogen linked to severe health conditions such as neuroinflammation and psychiatric disorders. This initiative coincided with Lyme Disease Awareness Month and aimed to deepen the understanding of Bartonella's behavior within the body, which is essential for developing more effective treatments for Bartonella infections and related conditions such as Lyme disease. The campaign highlighted the need for greater awareness and funding to assist individuals affected by these debilitating diseases.

In October 2024, R.E.D. Laboratories, a Belgium-based biomedical diagnostic company, collaborated with IGeneX Inc. to broaden access to IGeneX's advanced testing panels. Through this partnership, customers in Europe, Africa, and the Middle East can directly access IGeneX's specialized Lyme disease and co-infection tests via RED Labs. IGeneX Inc. is a US-based provider of diagnostic test kits for bartonellosis.

Major players in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio.

North America was the largest region in the bartonellosis market in 2024. The regions covered in bartonellosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bartonellosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bartonellosis market consists of revenues earned by entities by providing services such as medical consultation, symptom management, and vector control and prevention. The market value includes the value of related goods sold by the service provider or included within the service offering. The bartonellosis market includes sales of diagnostic kits, preventive products, pain relievers, and immune support supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bartonellosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bartonellosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bartonellosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bartonellosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Cat Scratch Disease (CSD); Trench Fever; Bartonella Endocarditis; Other Disease Types
• 2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing; Serological Testing; Culture Methods; Histological Testing
• 3) By Treatment: Antibiotics; Antibacterial Agents; Supportive Care
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End-Users
• Subsegments:
• 1) By Cat Scratch Disease (CSD): Immunocompetent Hosts; Immunocompromised Hosts; Neurological Complications
• 2) By Trench Fever: Acute Trench Fever; Chronic Trench Fever; Asymptomatic Infections
• 3) By Bartonella Endocarditis: Native Valve Endocarditis; Prosthetic Valve Endocarditis; Bloodstream Infections
• 4) By Other Disease Types: Bacillary Angiomatosis; Parinaud's Oculoglandular Syndrome; Bartonella-associated Vasculitis
• Companies Mentioned: Mayo Clinic Laboratories; Northwell Health Labs; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; IDEXX Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bartonellosis Market Characteristics

3. Bartonellosis Market Trends And Strategies

4. Bartonellosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bartonellosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bartonellosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bartonellosis Market Growth Rate Analysis
• 5.4. Global Bartonellosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bartonellosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bartonellosis Total Addressable Market (TAM)

6. Bartonellosis Market Segmentation

• 6.1. Global Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cat Scratch Disease (CSD)
• Trench Fever
• Bartonella Endocarditis
• Other Disease Types
• 6.2. Global Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Testing
• Serological Testing
• Culture Methods
• Histological Testing
• 6.3. Global Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antibacterial Agents
• Supportive Care
• 6.4. Global Bartonellosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Other End-Users
• 6.5. Global Bartonellosis Market, Sub-Segmentation Of Cat Scratch Disease (CSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunocompetent Hosts
• Immunocompromised Hosts
• Neurological Complications
• 6.6. Global Bartonellosis Market, Sub-Segmentation Of Trench Fever, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Trench Fever
• Chronic Trench Fever
• Asymptomatic Infections
• 6.7. Global Bartonellosis Market, Sub-Segmentation Of Bartonella Endocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Native Valve Endocarditis
• Prosthetic Valve Endocarditis
• Bloodstream Infections
• 6.8. Global Bartonellosis Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacillary Angiomatosis
• Parinaud's Oculoglandular Syndrome
• Bartonella-associated Vasculitis

7. Bartonellosis Market Regional And Country Analysis

• 7.1. Global Bartonellosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bartonellosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bartonellosis Market

• 8.1. Asia-Pacific Bartonellosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bartonellosis Market

• 9.1. China Bartonellosis Market Overview
• 9.2. China Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bartonellosis Market

• 10.1. India Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bartonellosis Market

• 11.1. Japan Bartonellosis Market Overview
• 11.2. Japan Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bartonellosis Market

• 12.1. Australia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bartonellosis Market

• 13.1. Indonesia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bartonellosis Market

• 14.1. South Korea Bartonellosis Market Overview
• 14.2. South Korea Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bartonellosis Market

• 15.1. Western Europe Bartonellosis Market Overview
• 15.2. Western Europe Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bartonellosis Market

• 16.1. UK Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bartonellosis Market

• 17.1. Germany Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bartonellosis Market

• 18.1. France Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bartonellosis Market

• 19.1. Italy Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bartonellosis Market

• 20.1. Spain Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bartonellosis Market

• 21.1. Eastern Europe Bartonellosis Market Overview
• 21.2. Eastern Europe Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bartonellosis Market

• 22.1. Russia Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bartonellosis Market

• 23.1. North America Bartonellosis Market Overview
• 23.2. North America Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bartonellosis Market

• 24.1. USA Bartonellosis Market Overview
• 24.2. USA Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bartonellosis Market

• 25.1. Canada Bartonellosis Market Overview
• 25.2. Canada Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bartonellosis Market

• 26.1. South America Bartonellosis Market Overview
• 26.2. South America Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bartonellosis Market

• 27.1. Brazil Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bartonellosis Market

• 28.1. Middle East Bartonellosis Market Overview
• 28.2. Middle East Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bartonellosis Market

• 29.1. Africa Bartonellosis Market Overview
• 29.2. Africa Bartonellosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bartonellosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bartonellosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bartonellosis Market Competitive Landscape And Company Profiles

• 30.1. Bartonellosis Market Competitive Landscape
• 30.2. Bartonellosis Market Company Profiles
  • 30.2.1. Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Northwell Health Labs Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bartonellosis Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Alberta Precision Laboratories
• 31.3. Jiangsu BioPerfectus Technologies Co. Ltd.
• 31.4. ARUP Laboratories
• 31.5. Surmodics Inc.
• 31.6. Medical Diagnostic Laboratories LLC
• 31.7. Creative Biolabs
• 31.8. IGeneX Inc.
• 31.9. Karius Inc.
• 31.10. Synnovis Group LLP
• 31.11. Galaxy Diagnostics Inc.
• 31.12. Gold Standard Diagnostics
• 31.13. Eurofins Biomnis
• 31.14. AMMAGENOMICS Private Limited
• 31.15. Ringbio

32. Global Bartonellosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bartonellosis Market

34. Recent Developments In The Bartonellosis Market

35. Bartonellosis Market High Potential Countries, Segments and Strategies

• 35.1 Bartonellosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bartonellosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bartonellosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer